Pacific Biosciences Of California (PACB) Assets (2010 - 2026)
Pacific Biosciences Of California's quarterly Assets came in at $782.4 million in Q1 2026, down 9.11% year-on-year from $860.8 million in Q1 2025, and little changed quarter-over-quarter from $784.1 million in Q4 2025.
Pacific Biosciences Of California has reported Assets for 17 years, with the latest figure at $782.4 million in Q1 2026.
- For the quarter ending Q1 2026, Assets fell 9.11% year-over-year to $782.4 million; the trailing twelve-month figure through Mar 2026 stood at $782.4 million (down 9.11% YoY), and the FY2025 full-year result was $784.1 million, down 37.79% from the prior year.
- Assets for Q1 2026 stood at $782.4 million, roughly flat from $784.1 million in the prior quarter.
- The five-year high for Assets was $1.9 billion in Q1 2022, with the low at $782.4 million in Q1 2026.
- Average Assets over 5 years is $1.5 billion, with a median of $1.7 billion recorded in 2024.
- Year-over-year, Assets jumped 54.58% in 2022 and plunged 48.45% in 2025.
- Tracing PACB's Assets over 5 years: stood at $1.8 billion in 2022, then decreased by 1.19% to $1.7 billion in 2023, then retreated by 27.81% to $1.3 billion in 2024, then sank by 37.79% to $784.1 million in 2025, then declined by 0.22% to $782.4 million in 2026.
- The last three Assets figures came in at $782.4 million (Q1 2026), $784.1 million (Q4 2025), and $803.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | 782.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 782.37 Mn |
| Dec 31, 2025 | 784.08 Mn |
| Sep 30, 2025 | 803.16 Mn |
| Jun 30, 2025 | 825.47 Mn |
| Mar 31, 2025 | 860.79 Mn |
| Dec 31, 2024 | 1.26 Bn |
| Sep 30, 2024 | 1.45 Bn |
| Jun 30, 2024 | 1.51 Bn |
| Mar 31, 2024 | 1.67 Bn |
| Dec 31, 2023 | 1.75 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.85 Bn |
| Mar 31, 2023 | 1.90 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 1.82 Bn |
| Jun 30, 2022 | 1.88 Bn |
| Mar 31, 2022 | 1.94 Bn |
| Dec 31, 2021 | 2.01 Bn |
| Jun 30, 2021 | 1.25 Bn |
| Mar 31, 2021 | 1.25 Bn |
| Dec 31, 2020 | 413.98 Mn |
| Sep 30, 2020 | 300.32 Mn |
| Jun 30, 2020 | 213.65 Mn |
| Mar 31, 2020 | 234.76 Mn |
| Dec 31, 2019 | 147.99 Mn |
| Sep 30, 2019 | 146.11 Mn |
| Jun 30, 2019 | 170.58 Mn |
| Mar 31, 2019 | 185.58 Mn |
| Dec 31, 2018 | 170.28 Mn |
| Sep 30, 2018 | 182.91 Mn |
| Jun 30, 2018 | 137.06 Mn |
| Mar 31, 2018 | 156.95 Mn |
| Dec 31, 2017 | 144.08 Mn |
| Sep 30, 2017 | 157.90 Mn |
| Jun 30, 2017 | 177.91 Mn |
| Mar 31, 2017 | 135.51 Mn |
| Dec 31, 2016 | 137.88 Mn |
| Sep 30, 2016 | 150.64 Mn |
| Jun 30, 2016 | 161.37 Mn |
| Mar 31, 2016 | 140.18 Mn |
| Dec 31, 2015 | 131.11 Mn |
| Sep 30, 2015 | 99.78 Mn |
| Jun 30, 2015 | 96.77 Mn |
| Mar 31, 2015 | 106.42 Mn |
| Dec 31, 2014 | 124.39 Mn |
| Sep 30, 2014 | 121.64 Mn |
| Jun 30, 2014 | 128.24 Mn |
| Mar 31, 2014 | 141.04 Mn |
| Dec 31, 2013 | 136.19 Mn |
| Sep 30, 2013 | 152.80 Mn |
| Jun 30, 2013 | 134.28 Mn |
| Dec 31, 2012 | 129.68 Mn |
| Mar 31, 2012 | 194.74 Mn |
| Dec 31, 2011 | 218.32 Mn |
| Sep 30, 2011 | 237.96 Mn |
| Jun 30, 2011 | 261.22 Mn |
| Dec 31, 2010 | 305.75 Mn |